Literature DB >> 32051074

[Management plan for prevention and control of novel coronavirus pneumonia among children in Xiangya Hospital of Central South University].

Jing Peng1, Xia Wang, Ming-Hua Yang, Ming-Jie Wang, Xiang-Rong Zheng.   

Abstract

Since December 2019, an epidemic of novel coronavirus pneumonia (NCP) has occurred in China. How to effectively prevent and control NCP among children with limited resources is an urgent issue to be explored. Under the unified arrangement of the Xiangya Hospital of Central South University, the Department of Pediatrics has formulated an action plan with Xiangya unique model to prevent and control NCP among children according to the current epidemic situation and diagnostic and therapeutic program in China.

Entities:  

Mesh:

Year:  2020        PMID: 32051074

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  4 in total

Review 1.  Hospitals' responsibility in response to the threat of infectious disease outbreak in the context of the coronavirus disease 2019 (COVID-19) pandemic: Implications for low- and middle-income countries.

Authors:  Ji Zhang; Xinpu Lu; Yinzi Jin; Zhi-Jie Zheng
Journal:  Glob Health J       Date:  2020-12-03

2.  The Recommendations for the Management of Chinese Children With Epilepsy During the COVID-19 Outbreak.

Authors:  Baiyu Chen; Miriam Kessi; Shimeng Chen; Juan Xiong; Liwen Wu; Xiaolu Deng; Lifen Yang; Fang He; Fei Yin; Jing Peng
Journal:  Front Pediatr       Date:  2020-08-25       Impact factor: 3.569

3.  Optimization model design of cross-border e-commerce transportation path under the background of prevention and control of COVID-19 pneumonia.

Authors:  Abuduaini Abudureheman; Aishanjiang Nilupaer
Journal:  Soft comput       Date:  2021-03-06       Impact factor: 3.643

4.  Strategic plan for management of COVID-19 in paediatric haematology and oncology departments.

Authors:  Yulei He; Zhi Lin; Daolin Tang; Yang Yang; Tianyou Wang; Minghua Yang
Journal:  Lancet Haematol       Date:  2020-04-01       Impact factor: 18.959

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.